The natural history and management of hepatorenal disorders: From pre-ascites to hepatorenal syndrome

Clinical Medicine

Volumn 3, Issue 2, 2003, Pages 154-159

  Blendis, Laurie ^a,c   Wong, Florence ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY OF TORONTO   (Canada)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Abdominal paracentesis; Ascites; Cirrhosis; Diuretics; Hepatorenal syndrome; Hyperkinetic circulation; Liver transplantation; Pre ascites; Transjugular intrahepatic hepatoportal shunt (TIPS); Vasodilatation

Indexed keywords

ANGIOTENSIN; DIURETIC AGENT; SODIUM; VASOCONSTRICTOR AGENT;

ARTERIAL BLOOD; ASCITES; BLOOD VESSEL; BLOOD VOLUME; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE COURSE; DIURESIS; GLOMERULUS FILTRATION RATE; HEPATORENAL SYNDROME; HISTORY; HUMAN; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE ABSORPTION; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PARACENTESIS; PORTOSYSTEMIC ANASTOMOSIS; PROPHYLAXIS; REVIEW; SODIUM RETENTION; STAGING; THEORY; VASCULAR CAPACITY; VASOCONSTRICTION; VASODILATATION;

EID: 0037362352     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-2-154     Document Type: Review

References (32)

1. Wong F, Blendis L. New challenge of hepatorenal syndrome: prevention and treatment. Hepatology 2001;34:1242-51.
2. Wong F, Liu P, Allidina Y, Blendis LM. Pattern and consequences of sodium handling in preascitic cirrhosis. Gastroenterology 1995;108: 1820-7.
3. Wong F, Liu P, Blendis LM. Sodium homeostasis in the chronic sodium loading in pre-ascitic cirrhosis. Gut 2001;49:847-51.
4. Schrier RW, Arroyo V, Bernardi M, Epstein M et al. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988;8:1151-7.
5. Bernardi M, Di Marco C, Trevisani F, Fornale L et al. Renal sodium retention during upright posture in pre-ascitic cirrhosis. Gastroenterology 1993;105:188-93.
6. Wong F, Logan AG, Blendis LM. Effects of insulin on renal hemodynamics, sodium homeostasis, forearm blood flow and sympathetic nervous activity in preascitic cirrhosis. Hepatology 1996;23:414-23.
7. Pozzi M, Grassi G, Redaelli E, Dell'Oro R et al. Patterns of regional sympathetic nerve traffic in pre-ascitic and ascitic cirrhosis. Hepatology 2001;34:1113-8.
8. Henriksen JH, Bendsten F, Sorenson TIA, Stadeager C et al. Reduced central blood volume in cirrhosis. Gastroenterology 1989;97:1506-13.
9. Wong F, Liu P, Tobe S, Morali G et al. Central blood volume in cirrhosis: measurement by radionuclide angiography. Hepatology 1994;19:12-21.
10. Warner L, Skorecki K, Blendis LM, Epstein M. Atrial natriuretic factor and liver disease. Hepatology 1993;17:500-13.
11. Girgrah N, Liu P, Collier J, Blendis L, Wong F. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, and angiotensin II receptor antagonist, in preascitic cirrhosis. Gut 2000;46:114-20.
12. Wong F, Liu P, Blendis L. The mechanism of improved sodium homeostasis of low dose losartan in preascitic cirrhosis. Hepatology 2002;35: 1449-58.
13. Morali GA, Sniderman KW, Dietel KM, Witte O et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol 1992;16:249-50.
14. Sarela AJ, Milhaimeed A, Batten JJ, Davidson BR, and Maithie RT. Hepatic and splanchnic nitric oxide activity in patients with cirrhosis. Gut 1999;44:749-53.
15. Fernandez-Seara J, Prieto J, Quiroga J, Zozaya JM et al. Systemic and regional hemodynamics in patients with liver cirrhosis and ascites, with and without renal failure. Gastroenterology 1989;97:1304-12.
16. Floras JS, Legault L, Morali GA, Hara K, Blendis LM. Increased sympathetic outflow in cirrhosis and ascites: direct evidence from intraneural recordings. Ann Int Med 1991;114:373-80.
17. Gentilini P, Laffi G, La Villa G, Romanelli RG, Blendis LM. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication? J Hepatol 1999;30:1088-97.
18. Gatta A, Angeli P, Caregaro L, Menon F et al. A pathophysiological interpretation of unresponsiveness to spironolactone in a stepped-care approach to the diuretic treatment of ascites in nonazotemic cirrhotic patients. Hepatology 1991;14:231-6.
19. Arroyo V, Gines P, Gerbes AL, Dudley FJ et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23:164-76.
20. Morali GA, Tobe SW, Skorecki KL, Blendis LM. Refractory ascites: modulation of ANF unresponsiveness by mannitol. Hepatology 1992;16:42-8.
21. Gines P, Arroyo V, Quintero E, Planas R et al. Comparison of paracentesis and diuretics in the treatment of cirrhosis with tense ascites. Results of a randomized trial. Gastroenterology 1987;93:234-41.
22. Peltekian K, Wong F, Liu P, Allidina Y et al. The effect of large volume paracentesis on total central blood volume. Am J Gastroenterol 1997;92:394-9.
23. Ruiz-del Arbol L, Monescillo A, Jimenez W, Garcia-Plaza A et al. Paracentesis-induced circulatory dysfunction: mechanism and the effect on hepatic hemodynamics in cirrhosis. Gastroenterology 1997;113:579-86.
24. Wong F, Sniderman K, Liu P, Allidina Y et al. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites. Ann Int Med 1995; 122:816-22.
25. Wong W, Liu P, Blendis L, Wong F. Renal sodium handling during long-term follow-up and the effect of sodium loading in cirrhotic patients treated with TIPS for refractory ascites. Am J Med 1999;106:315-22.
26. Rossle M, Ochs A, Gulberg V, Siegerstettier V et al. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites. N Engl J Med 2000;342:1701-7.
27. Moreau R, Durand F, Poynard T, Duhamel C et al. Terlipressin in patients with cirrhosis and type I hepatorenal syndrome: a retrospective multicenter study. Gastroenterology 2002;122:923-30.
28. Gonwa TA, Morris CA, Goldstein RM, Husberg BS, Klintmalm GB. Long-term survival and renal function following liver transplanation in patients with and without hepatorenal syndrome-experience in 300 patients. Transplantation 1991;51:428-30.
29. Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology 2002;35:1179-85.
30. Jeyarah DR, Gonwa TA, McBride M, Testa G et al. Hepatorenal syndrome: combined liver kidney transplant versus isolated liver transplant. Transplantation 1997;64:1760-5.
31. Mitzner SR, Stange J, Klammt S, Risler T et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective randomized, controlled clinical trial. Liver Transpl 2000;6:277-86.
32. Brensing KA, Textor J, Perz J, Schiedermaier P et al. Long-term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study. Gut 2000;47:288-95.